SEARCH RESULT

Total Matching Records found : 501

From approval to appraisal

The government’s subtle, but significant, move to divest the Genetic Engineering Approval Committee (GEAC) of its job of approving the genetically modified (GM) products and convert it into merely a GM appraisal body has taken the biotechnology sector by surprise. The Gazette notification to this effect replaces the word “approval” in the committee’s nomenclature with “appraisal”, thus making it the “Genetic Engineering Appraisal Committee”. One obvious reason for doing so...

More »

Trade Talks with EU Put Drug Manufacturers on Edge by Keya Acharya

Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...

More »

Monsanto seeds - For good or evil?

Technology… the knack of so arranging the world that we don’t have to experience it — Max Frisch, Swiss novelist and playwright Why do MNCs excite extreme emotions in India ? If you take any one of them from banks to pharma and chemicals to defence and aerospace, they are all clubbed together with the “usual suspects” who do more harm than good despite all the good intentions they might have had....

More »

Acute shortage of doctors, paramedics in rural areas by Kounteya Sinha

The shortage of doctors and paramedical staff for the country's poor and downtrodden is assuming alarming proportions. According to the latest data on rural health statistics, a huge number of posts sanctioned for medical staff in primary and community health centers have been lying vacant. Consider the case of primary health centres. The vacancies stack up to 5,224 doctors, 7,243 health care workers and 1701 health assistants, respectively. The situation...

More »

Three firms rank highest on access to poor by Donald G. Mcneil Jr

GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world's poor. It was the second time the rankings, which were created in 2008, have been issued. This time, 95 per cent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information;...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close